Jiayuh Lin

10.3k total citations · 1 hit paper
137 papers, 8.6k citations indexed

About

Jiayuh Lin is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Jiayuh Lin has authored 137 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Oncology, 78 papers in Molecular Biology and 25 papers in Pathology and Forensic Medicine. Recurrent topics in Jiayuh Lin's work include Cytokine Signaling Pathways and Interactions (85 papers), Cancer-related Molecular Pathways (26 papers) and Cancer Mechanisms and Therapy (25 papers). Jiayuh Lin is often cited by papers focused on Cytokine Signaling Pathways and Interactions (85 papers), Cancer-related Molecular Pathways (26 papers) and Cancer Mechanisms and Therapy (25 papers). Jiayuh Lin collaborates with scholars based in United States, China and Taiwan. Jiayuh Lin's co-authors include Arnold J. Levine, Chenglong Li, Pui‐Kai Li, Li Lin, Hui Song, Jiandong Chen, Brian Elenbaas, James R. Fuchs, Shaomeng Wang and Melinda Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

Jiayuh Lin

131 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.

1994 561 citations Jiayuh Lin et al. profile →

Peers

Countries citing papers authored by Jiayuh Lin

Since Specialization

Citations

This map shows the geographic impact of Jiayuh Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiayuh Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiayuh Lin more than expected).

Fields of papers citing papers by Jiayuh Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiayuh Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiayuh Lin. The network helps show where Jiayuh Lin may publish in the future.

Co-authorship network of co-authors of Jiayuh Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jiayuh Lin. A scholar is included among the top collaborators of Jiayuh Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiayuh Lin. Jiayuh Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CDK4/6 inhibitors in lung cancer: current practice and future directions 2024 ·European Respiratory Review ·(unknown), Jie Yang, Jiayuh Lin, Xiaoying Huang, (unknown), Chengguang Zhao, Lehe Yang	19
2	Bazedoxifene as a Potential Cancer Therapeutic Agent Targeting IL-6/GP130 Signaling 2024 ·Current Oncology ·(unknown), (unknown), Hui‐Wen Lo, Katherine H. R. Tkaczuk, Jiayuh Lin	6
3	Novel activators and small-molecule inhibitors of STAT3 in cancer 2019 ·Cytokine & Growth Factor Reviews ·Lehe Yang, (unknown), Lingyuan Xu, Jiayuh Lin, Chengguang Zhao, Xiaoying Huang	98
4	Discovery of an Orally Selective Inhibitor of Signal Transducer and Activator of Transcription 3 Using Advanced Multiple Ligand Simultaneous Docking 2017 ·Journal of Medicinal Chemistry ·Wenying Yu, Chenglong Li, Wenda Zhang, Yuan‐Zheng Xia, Shanshan Li, Jiayuh Lin, Keqin Yu, Mu Liu, (unknown), Jian‐Guang Luo, Yijun Chen, Hongbin Sun, Lingyi Kong	41
5	Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma 2013 ·Clinical Cancer Research ·Hemant K. Bid, (unknown), Doris A. Phelps, (unknown), Linlin Xiao, Jiayuh Lin, David Capper, (unknown), Brian Geier, Mariko DeWire, Paul D. Smith, Raushan T. Kurmasheva, Xiaokui Mo, Soledad Fernández, Peter J. Houghton	49
6	HAb18G/CD147 Promotes pSTAT3-Mediated Pancreatic Cancer Development via CD44s 2013 ·Clinical Cancer Research ·Ling Li, Wenhua Tang, Xiaoqing Wu, David Karnak, Xiaojie Meng, R. Thompson, Xinbao Hao, Yongmin Li, Xiaotan T. Qiao, Jiayuh Lin, James R. Fuchs, Diane M. Simeone, Zhi‐Nan Chen, Theodore S. Lawrence, Liang Xu	57
7	ΔNp63 Promotes Pediatric Neuroblastoma and Osteosarcoma by Regulating Tumor Angiogenesis 2013 ·Cancer Research ·Hemant K. Bid, Ryan D. Roberts, Maren Cam, Anthony Audino, Raushan T. Kurmasheva, Jiayuh Lin, Peter J. Houghton, Hakan Çam	47
8	Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells 2013 ·PLoS ONE ·Li Lin, Brian Hutzen, (unknown), Zhengang Peng, Wenlong Wang, (unknown), Huey-Jen Lin, Duxin Sun, Pui‐Kai Li, Chenglong Li, Hasan Körkaya, Max S. Wicha, Jiayuh Lin	60
9	Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines 2012 ·BMC Veterinary Research ·(unknown), Misty D. Bear, Jiayuh Lin, (unknown), Samuel K. Kulp, William C. Kisseberth, Cheryl A. London	18
10	STAT3 Is Necessary for Proliferation and Survival in Colon Cancer–Initiating Cells 2011 ·Cancer Research ·Li Lin, Aiguo Liu, Zhengang Peng, Huey‐Jen Lin, Pui‐Kai Li, Chenglong Li, Jiayuh Lin	251
11	Celecoxib Inhibits Interleukin-6/Interleukin-6 Receptor–Induced JAK2/STAT3 Phosphorylation in Human Hepatocellular Carcinoma Cells 2011 ·Cancer Prevention Research ·Yan Liu, Aiguo Liu, Huameng Li, Chenglong Li, Jiayuh Lin	54
12	LLL12 inhibits endogenous and exogenous interleukin-6-induced STAT3 phosphorylation in human pancreatic cancer cells. 2011 ·PubMed ·Aiguo Liu, Yan Liu, Pui‐Kai Li, Chenglong Li, Jiayuh Lin	27
13	Novel small molecule, XZH‐5, inhibits constitutive and interleukin‐6‐induced STAT3 phosphorylation in human rhabdomyosarcoma cells 2011 ·Cancer Science ·Aiguo Liu, Yan Liu, Zhenghu Xu, Wenying Yu, Hong Wang, Chenglong Li, Jiayuh Lin	23
14	Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells 2010 ·Cancer Research ·Li Lin, Brian Hutzen, Mingxin Zuo, Sarah Ball, Stephanie Deangelis, Elizabeth Foust, Bulbul Pandit, Michael A. Ihnat, Satyendra S. Shenoy, Samuel K. Kulp, Pui‐Kai Li, Chenglong Li, James R. Fuchs, Jiayuh Lin	197
15	IL-6, a risk factor for hepatocellular carcinoma: FLLL32 inhibits IL-6-Induced STAT3 phosphorylation in human hepatocellular cancer cells 2010 ·Cell Cycle ·Yan Liu, James R. Fuchs, Chenglong Li, Jiayuh Lin	62
16	LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model 2009 ·British Journal of Cancer ·Beng Fuh, Matthew Sobo, (unknown), (unknown), Brian Hutzen, Katryna Cisek, Deepak K. Bhasin, Nicholas Regan, Li Lin, Carina K. Y. Chan, Heloisa Cristina Caldas, Stephanie Deangelis, (unknown), Pui‐Kai Li, Jiayuh Lin	75
17	Paracrine signaling from the breast cancer cells stimulates the cell proliferation and Stat3 phosphorylation in non-cancerous mammary epithelial cells and is blocked by dietary agent, curcumin. 2007 ·Cancer Epidemiology and Prevention Biomarkers ·(unknown), Sarah Ball, Brian Hutzen, Zhongfa Liu, Jiayuh Lin	2
18	Inhibition of AKT survival pathway by a small molecule inhibitor in human endometrial cancer cells 2004 ·British Journal of Cancer ·Xingyi Jin, Dana R. Gossett, Shaomeng Wang, Dajun Yang, Yang Cao, J. Chen, Ribo Guo, R. Kevin Reynolds, Jiayuh Lin	62
19	17-Allyamino-17-demethoxygeldanamycin and 17-NN-dimethyl ethylene diamine-geldanamycin have cytotoxic activity against multiple gynecologic cancer cell types 2004 ·Gynecologic Oncology ·Dana R. Gossett, Megan S. Bradley, Xiaohong Jin, Jiayuh Lin	18
20	Analysis of Wild-Type and Mutant p21 WAF-1 Gene Activities 1996 ·Molecular and Cellular Biology ·Jiayuh Lin, (unknown), Xiangwei Wu, A J Levine	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact